期刊文献+

急性白血病并发革兰阴性菌血流感染病原菌及其危险因素 被引量:2

Pathogens isolated from acute leukemia patients complicated with gram-negative bacteria bloodstream infection and risk factors
原文传递
导出
摘要 目的分析急性白血病革兰阴性菌血流感染患者主要病原菌构成及感染危险因素。方法回顾性收集2018年3月-2022年3月黄冈市中心医院收治的179例急性白血病患者的临床资料,根据患者发病后10 d是否发生革兰阴性菌血流感染情况分为革兰阴性菌血流感染组(70例)和无革兰阴性菌血流感染组(109例)。统计急性白血病革兰阴性菌血流感染患者革兰阴性菌分布情况,另采用单因素及多因素Logistic回归分析急性白血病患者革兰阴性菌血流感染的危险因素。结果革兰阴性菌血流感染组患者的痰液样本中共分离出70株革兰阴性菌:肠杆菌41株(58.57%),非发酵菌23株(32.86%),其他6株(8.57%)。多因素结果显示,不合理使用抗菌药物、住院时间>30 d、合并肛周疾病、中性粒细胞缺乏持续时间≥7 d、血清清蛋白<35 g/L、血红蛋白水平<30 g/L、白细胞计数<4×10^(9)/L均为影响急性白血病患者革兰阴性菌血流感染的危险因素,差异有统计学意义(均P<0.05)。结论临床可据影响急性白血病患者革兰阴性菌血流感染的各项危险因素进行针对性治疗及干预,以降低患者革兰阴性菌血流感染率,改善预后。 OBJECTIVE To analyze the main pathogenic bacteria composition and risk factors in acute leukemia patients with gram-negative bacteria bloodstream infection.METHODS Clinical data of 179 patients with acute leukemia admitted to Huanggang Central Hospital from Mar 2018 to Mar 2022 were retrospectively collected.According to whether gram-negative bacteria bloodstream infection occurred 10 days after the onset of the disease,the patients were divided into the gram-negative bacteria bloodstream infection group(70 cases)and non-gram-negative bacteria bloodstream infection group(109 cases).The distribution of gram-negative bacteria in patients with acute leukemia complicated with gram-negative bacteria bloodstream infection was analyzed.The risk factors for gram-negative bacteria bloodstream infection in patients with acute leukemia were analyzed by univariate and multivariate logistic regression.RESULTS A total of 70 strains of gram-negative bacteria were isolated from sputum samples of patients with blood flow infection,including 41 strains(58.57%)of Enterobacteriaceae,23 strains(32.86%)of non-fermenting bacteria,and 6 strains(8.57%)of others.The multivariate logistic regression analysis showed that irrational use of antibiotics,hospital stay 30 d,combined perianal disease,arteriovenous intubation,blood transfusion,neutropenia duration≥7 d,serum albumin <35 g/L,hemoglobin level>30 g/L,and white blood cell count<4×10^(9)/L were all risk factors for gram-negative bacteria bloodstream infection in acute leukemia patients,and the differences were significant(all P<0.05).CONCLUSION Clinical treatment and intervention can be carried out according to the risk factors affecting gram-negative bacteria bloodstream infection in patients with acute leukemia,so as to reduce the infection rate of gram-negative bacteria bloodstream and improve the prognosis.
作者 孙元利 桂瑞丰 王科 刘海叶 尹志红 SUN Yuan-li;GUI Rui-feng;WANG Ke;LIU Hai-ye;YIN Zhi-hong(Huanggang Central Hospital,Huanggang,Hubei 438000,China)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2023年第7期996-1000,共5页 Chinese Journal of Nosocomiology
基金 湖北省科研基金资助项目(2020K0321)。
关键词 白血病 急性 血流感染 革兰阴性菌 病原菌 危险因素 Leukemia Acute Bloodstream infection Gram-negative bacteria Pathogen Risk factors
  • 相关文献

参考文献7

二级参考文献46

  • 1汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 2FreifeldAG, BowEJ, SepkowitzKA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2011, 52(4):427-431. doi: 10.1093/cid/ciq147.
  • 3AverbuchD, OraschC, CordonnierC, et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia [J]. Haematologica, 2013, 98(12):1826-1835. doi: 10.3324/haematol.2013.091025.
  • 4AverbuchD, CordonnierC, LivermoreDM, et al. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)[J]. Haematologica, 2013, 98(12):1836-1847. doi: 10.3324/haematol.2013.091330.
  • 5ZhaiW, ZhangX, WeiJ, et al. A Prospective Observational Study of Antibiotic Therapy in Febrile Neutropenia Patients with Hematological Malignances from Multiple centers in Northeast China [J]. Int J Infect Dis, 2015, 37:97-103. doi: 10.1016/j.ijid.2015.04.015.
  • 6KernWV, MarchettiO, DrgonaL, et al. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV [J]. J Clin Oncol, 2013, 31(9):1149-1156. doi: 10.1200/JCO.2012.45.8109.
  • 7WunderinkRG, RelloJ, CammarataSK, et al. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia[J]. Chest, 2003, 124(5):1789-1797.
  • 8ChaftariAM, HachemR, MulanovichV, et al. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients [J]. Int J Antimicrob Agents, 2010, 36(2):182-186. doi: 10.1016/j.ijantimicag.2010.03.015.
  • 9Gafter-GviliA, FraserA, PaulM, et al. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy [J]. Cochrane Database Syst Rev, 2012, 1:CD004386. doi: 10.1002/14651858.CD004386.pub3.
  • 10RazonableRR, LitzowMR, KhaliqY, et al. Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis [J]. Clin Infect Dis, 2002, 34(11):1469-1474. doi: 10.1086/340352.

共引文献6161

同被引文献24

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部